Elicio Therapeutics, Inc. (ELTX): Long-Term Debt
$10.00M
As of 2025-12-31
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.00M | n/a | 2026-03-12, Balance as of period end |
Long-Term Debt at similar companies
| Company | Year ended | Long-Term Debt | Change YoY |
|---|---|---|---|
| Elicio Therapeutics, Inc. (ELTX) | 2025-12-31 | $10.00M | n/a |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $0 | -100.0% |
| Gain Therapeutics, Inc. (GANX) | 2025-12-31 | $401.0K | -8.6% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $0 | n/a |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | $27.13M | -6.3% |
| Jyong Biotech Ltd. (MENS) | 2025-12-31 | $2.12M | n/a |
| Propanc Biopharma, Inc. (PPCB) | 2025-06-30 | $537.9K | +34.7% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2025-03-31 | $807.2K | +27.8% |
| Clene Inc. (CLNN) | 2025-12-31 | $17.79M | n/a |
Compare ELTX, HCWB, GANX, YARW side by side · Screen every company in Pharmaceutical Preparations ↗